Referències cientifíques — Creatina

RENDIMENT, FORÇA I COMPOSICIÓ CORPORAL

[1] Desai I, et al. The Effect of Creatine Supplementation on Resistance Training-Based Changes to Body Composition: A Systematic Review and Meta-analysis. J Strength Cond Res. 2024. PMID 39074168.

https://pubmed.ncbi.nlm.nih.gov/39074168

[2] Wang Z, et al. Effects of Creatine Supplementation and Resistance Training on Muscle Strength Gains in Adults menor de 50 Years of Age: A Systematic Review and Meta-Analysis. Nutrients. 2024. PMID 39519498.

https://pubmed.ncbi.nlm.nih.gov/39519498

[3] Forbes SC, et al. Effect of creatine supplementation during resistance training on lean tissue mass and muscular strength in older adults: a meta-analysis. Appl Physiol Nutr Metab. 2019. PMID 29138605.

https://pubmed.ncbi.nlm.nih.gov/29138605

[4] Impact of creatine supplementation associated with resistance training on muscular strength and lean tissue mass in the aged: a systematic review and meta-analysis. 2025. PMID 41388441.

https://pubmed.ncbi.nlm.nih.gov/41388441

NEUROLOGIA I FUNCIÓ COGNITIVA

[5] Xu C, et al. The effects of creatine supplementation on cognitive function in adults: a systematic review and meta-analysis. Front Nutr. 2024. PMID 39070254.

https://pubmed.ncbi.nlm.nih.gov/39070254

[6] Creatine supplementation research fails to support the theoretical basis for an effect on cognition: Evidence from a systematic review. Behav Brain Res. 2024. PMID 38582412.

https://pubmed.ncbi.nlm.nih.gov/38582412

ONCOLOGIA — EVIDÈNCIA EN HUMANS

[7] Del Arco A, et al. Effect of Creatine Supplementation on Body Composition in Cancer Patients: A Systematic Review. Nutr Cancer. 2025. PMID 40536429.

https://pubmed.ncbi.nlm.nih.gov/40536429

Revisió de 7 estudis i 463 participants. Els resultats sobre composició corporal són limitats i no permeten establir un benefici clínic general.

ONCOLOGIA — EVIDÈNCIA PRECLÍNICA

[8] Creatine Supplementation in Preclinical Models Receiving Immune Checkpoint Inhibitor Therapy: A Systematic Review. 2026. PMID 42255854.

https://pubmed.ncbi.nlm.nih.gov/42255854

[9] Xie S, et al. Exogenous creatine supplementation promotes tumor metastasis via megakaryocyte creatine kinase B-STAT5B signaling. Nat Commun. 2026. PMID 42449108.

https://pubmed.ncbi.nlm.nih.gov/42449108

[10] Zhang L, et al. Creatine promotes cancer metastasis through activation of Smad2/3. Cell Metab. 2021. PMID 33811821.

https://pubmed.ncbi.nlm.nih.gov/33811821

Nota editorial: aquestes fonts preclíniques no demostren que la creatina provoqui metàstasi en humans. Serveixen per explicar per què existeix una pregunta de recerca i per què en oncologia cal prudència.

SEGURETAT

[11] Kreider RB, et al. Safety of creatine supplementation: analysis of the prevalence of reported side effects in clinical trials and adverse event reports. 2025. PMID 40198156.

https://pubmed.ncbi.nlm.nih.gov/40198156

[12] Creatine Supplementation Dose and Duration Are Not Associated with Increased Side Effects: A Structured Review and Study-Level Dose-Response Analysis of Randomized Controlled Trials. 2026. PMID 42043069.

https://pubmed.ncbi.nlm.nih.gov/42043069

[13] Impact of creatine supplementation on kidney health: a systematic review and meta-analysis. 2026. PMID 42507286.

https://pubmed.ncbi.nlm.nih.gov/42507286